Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Biller

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
Science (New York, N.Y.)|October 1, 1976
Search for organic and volatile inorganic compounds in two surface samples from the chryse planitia region of MarsK Biemann, J Oro, P Toulmin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 21, 2024
Vitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosisAndrew T Braun, HuiChuan J Lai, Anita Laxova, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2021
Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V Nagaraja, Bin Fan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 16, 2010
High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discoveryMadhu S Mondal, Joseph Gabriels, Claudia McGinnis, et al.
Blood|November 16, 2014
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibitionAndrew Kernytsky, Fang Wang, Erica Hansen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cellsH Jamil, D A Gordon, D C Eustice, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agentsDavid R Magnin, Scott A Biller, John Wetterau, et al.
Nature Communications|January 11, 2019
Structure and inhibition mechanism of the catalytic domain of human squalene epoxidaseAnil K Padyana, Stefan Gross, Lei Jin, et al.
Cell Reports|April 13, 2016
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 AxisKatya Marjon, Michael J Cameron, Phong Quang, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2008
Tetrazole based amides as growth hormone secretagoguesJames J Li, Haixia Wang, Jun Li, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
Science (New York, N.Y.)|October 1, 1976
Search for organic and volatile inorganic compounds in two surface samples from the chryse planitia region of MarsK Biemann, J Oro, P Toulmin, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|February 21, 2024
Vitamin D status and variable responses to supplements depend in part on genetic factors in adults with cystic fibrosisAndrew T Braun, HuiChuan J Lai, Anita Laxova, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 29, 2021
Preclinical Drug Metabolism, Pharmacokinetic, and Pharmacodynamic Profiles of Ivosidenib, an Inhibitor of Mutant Isocitrate Dehydrogenase 1 for Treatment of Isocitrate Dehydrogenase 1-Mutant MalignanciesYue Chen, Nelamangala V Nagaraja, Bin Fan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|July 16, 2010
High-content micronucleus assay in genotoxicity profiling: initial-stage development and some applications in the investigative/lead-finding studies in drug discoveryMadhu S Mondal, Joseph Gabriels, Claudia McGinnis, et al.
Blood|November 16, 2014
IDH2 mutation-induced histone and DNA hypermethylation is progressively reversed by small-molecule inhibitionAndrew Kernytsky, Fang Wang, Erica Hansen, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 15, 1996
An inhibitor of the microsomal triglyceride transfer protein inhibits apoB secretion from HepG2 cellsH Jamil, D A Gordon, D C Eustice, et al.
Bioorganic & Medicinal Chemistry Letters|March 27, 2003
Microsomal triglyceride transfer protein inhibitors: discovery and synthesis of alkyl phosphonates as potent MTP inhibitors and cholesterol lowering agentsDavid R Magnin, Scott A Biller, John Wetterau, et al.
Nature Communications|January 11, 2019
Structure and inhibition mechanism of the catalytic domain of human squalene epoxidaseAnil K Padyana, Stefan Gross, Lei Jin, et al.
Cell Reports|April 13, 2016
MTAP Deletions in Cancer Create Vulnerability to Targeting of the MAT2A/PRMT5/RIOK1 AxisKatya Marjon, Michael J Cameron, Phong Quang, et al.
Bioorganic & Medicinal Chemistry Letters|April 2, 2008
Tetrazole based amides as growth hormone secretagoguesJames J Li, Haixia Wang, Jun Li, et al.
Pageof 8